NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
McDonagh MS, Selover D, Santa J, et al. Drug Class Review on Agents for Overactive Bladder: Final Report [Internet]. Portland (OR): Oregon Health & Science University; 2005 Dec.
This publication is provided for historical reference only and the information may be out of date.
< PrevNext >
Table 1. Comparative clinical trials
Table 3. Trials with OAB drugs versus another drug
Table 4. OAB drugs versus non-drug therapy
Table 5. OAB drugs versus placebo
Table 6. Assessment of abstracts for publication bias
Table 7. OAB observational studies: Adverse events
- Evidence Tables - Drug Class Review on Agents for Overactive BladderEvidence Tables - Drug Class Review on Agents for Overactive Bladder
- Summary and Discussion - Drug Class Review on Agents for Overactive BladderSummary and Discussion - Drug Class Review on Agents for Overactive Bladder
- Mus musculus phosphodiesterase 4B, cAMP specific, mRNA (cDNA clone IMAGE:3485809...Mus musculus phosphodiesterase 4B, cAMP specific, mRNA (cDNA clone IMAGE:3485809), partial cdsgi|13938078|gb|BC007155.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...